Predicting response to chemoradiotherapy in rectal cancer via visual morphologic assessment and staging on baseline MRI: a multicenter and multireader study

Frans C.H. Bakers, M.D. (Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands); Perla Barros, M.D. (Department of Radiology, Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile); Ferdinand Bauer, M.D. (Radiologie Zentrum, Kaufbeuren, Germany); Shira H. de Bie, M.D. (Department of Radiology, Deventer Ziekenhuis, The Netherlands); Stuart Ballantyne, M.D. (Department of Radiology, Queen Elizabeth University Hospital, Glasgow, United Kingdom); Joanna Brayner Dutra, M.D. (Department of Radiology, Real Hospital Portugues (RHP), Recife, Brazil), (Department of Radiology, Instituto de Medicina Integral Professor Fernando Figueira (IMIP), Recife, Brazil); Laura Buskov, M.D. (Department of Radiology, Bispebjerg Hospital, Copenhagen, Denmark); Nino Bogveradze, M.D. (Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands), (GROW School for Oncology & Developmental Biology, University of Maastricht, Maastricht, The Netherlands), (Department of Radiology, American Hospital Tbilisi, Tbilisi, Georgia); Gerlof P.T. Bosma, MA MD PhD. (Department of Radiology Elisabeth Tweesteden Hospital, Tilburg, The Netherlands); Vincent C. Cappendijk, M.D., Ph.D. (Department of Radiology, Jeroen Bosch Hospital, ‘s Hertogenbosch, The Netherlands); Francesca Castagnoli, M.D. (Department of Radiology, Royal Marsden Hospital, Sutton, UK); Sotiriadis Charalampos, M.D. (Department of Radiology, Hôpital Riviera Chablais, Rennaz, Switzerland); Andrea Delli Pizzi, M.D. (Department of Innovative Technologies in Medicine & Dentistry, Gabriele d’Annunzio University of Chieti, Chieti, Italy); Michael Digby, M.D. (Department of Radiology, Glasgow Royal Infirmary, Glasgow, United Kingdom); Remy W.F. Geenen, M.D. (Department of Radiology, Northwest Clinics, Alkmaar, The Netherlands); Joost J.M. van Griethuysen, M.D., Ph.D. (Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands), (Department of Radiology, Gelre Hospital, Apeldoorn, The Netherlands); Julie Lafrance, M.D. (Department of Radiology, Maisonneuve-Rosemont Hospital, Montreal, Canada); Vandana Mahajan, M.D. (Department of Radiology, Apollo Cancer Hospital, Chennai, India); Sonaz Malekzadeh, M.D. (Department of Radiology, Sion Hospital, Sion, Switzerland); Peter A. Neijenhuis, M.D. (Department of Surgery, Alrijne Hospital, Leiderdorp, The Netherlands); Gerald M. Peterson, M.D. (Department of Radiology, Spaarne Gasthuis, Haarlem, The Netherlands); Indra Pieters, M.D. (TMC, a Unilabs company. Barcelona, Spain); Niels W. Schurink, M.Sc., Ph.D. (Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands), (GROW School for Oncology & Developmental Biology, University of Maastricht, Maastricht, The Netherlands); Ruth Smit, M.D. (Department of Radiology, Amsterdams UMC, Amsterdam, The Netherlands); Cornelis J. Veeken, M.D. (Department of Radiology, IJsselland Hospital, Capelle aan den IJssel, The Netherlands); Roy F.A. Vliegen, M.D. (Department of Radiology, Zuyderland Medical Center, Heerlen, The Netherlands); Andrew Wray, M.D. (Department of Radiology, Ulster Hospital, Belfast, United Kingdom); Abdel-Rauf Zeina, M.D. (Department of Radiology, Hillel Yaffe Medical Center, Hadera, Israel).

留言 (0)

沒有登入
gif